Lyophilised hGH Fragment 176–191, 5 mg, with 3 mL bacteriostatic water in a research laboratory.
Buy Blue Xanax Bars B707 Price range: €118.88 through €380.42
Back to products
Lyophilised hGH Fragment 176–191, 5 mg, with 3 mL bacteriostatic water in a research laboratory.
Buy Clonazolam Pellets 1mg Price range: €57.06 through €209.23

Buy Bromonordiazepam 2.5 MG Pellets

Price range: €13.95 through €219.95

Certified ≥99% pure Bromonordiazepam 2.5mg pellets for forensic toxicology and in vitro analytical research. Strictly laboratory use. Rapid, discreet EU shipping from Pharma Research .eu with full CoA.

Quantity

10 Pellets

,

20 Pellets

,

50 Pellets

,

100 Pellets

,

250 Pellets

SKU: N/A Category:
Description

Buy Bromonordiazepam 2.5mg Pellets for Advanced Laboratory Research in Europe

Bromonordiazepam (also known as desalkylgidazepam or 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one) represents a pharmacologically significant benzodiazepine metabolite of considerable interest to forensic toxicology laboratories and GABA-A receptor research facilities across the European Union. As the major human metabolite of gidazepam and a compound that has emerged in the designer benzodiazepine market, this substance serves as an essential analytical reference standard for mass spectral library development, method validation, and receptor-binding assay calibration in modern toxicological screening. Pharma Research .eu stands as the definitive EU source for this rigorously characterised material, supplying certified reference quantities exclusively to qualified laboratory professionals engaged in controlled in vitro investigation and forensic analytical work.

Uncompromising Purity and Analytical Characterisation

Every batch of Bromonordiazepam 2.5mg Pellets supplied by Pharma Research .eu is guaranteed to meet a minimum purity specification of ≥99%, as verified through comprehensive high-performance liquid chromatography (HPLC) analysis coupled with orthogonal confirmation via gas chromatography–mass spectrometry (GC-MS) and, where applicable, nuclear magnetic resonance (NMR) spectroscopy. This exceptional purity threshold is non-negotiable for producing reproducible, publishable research outcomes in forensic toxicology and analytical chemistry, where even minor impurities can compromise mass spectral library matching, quantification accuracy, and method validation parameters.

Each shipment is accompanied by a comprehensive Certificate of Analysis (CoA) documenting batch-specific analytical data, including retention time verification, peak purity assessment, and identity confirmation through mass spectral fragmentation pattern matching. The CoA further certifies that residual solvent analysis has been performed in accordance with ICH Q3C guidelines, with all detected solvents quantified well below permitted daily exposure limits. Heavy metal content is similarly verified to comply with ICH Q3D elemental impurities thresholds, ensuring the material meets the stringent requirements expected of analytical reference standards used in regulated laboratory environments.

Bromonordiazepam is supplied in the form of precisely compressed 2.5mg pellets, offering a convenient solid-state format for analytical laboratories requiring accurate milligram-scale quantities for reference standard preparation and serial dilution workflows. The pellets present as uniform, off-white to pale cream compressed solids with consistent dimensions and mass, facilitating accurate weighing and stock solution preparation. This physical form is verified through visual inspection and mass verification protocols prior to release, ensuring each pellet conforms to specified tolerances.

The significance of this purity level cannot be overstated when contrasted with lower-grade industrial reagents or uncertified materials available through non-specialist channels. In forensic toxicology applications, where Bromonordiazepam serves as a certified reference material (CRM) for LC-MS/MS and GC-MS method development, impurities at even 0.5% can generate confounding mass spectral peaks, compromise calibration curve linearity, and introduce systematic bias into quantitative results. For receptor-binding assays and in vitro metabolic stability profiling using human hepatocyte cultures, sub-standard purity introduces uncontrolled variables that invalidate structure-activity relationship conclusions and compromise the integrity of pharmacological data. Pharma Research .eu’s commitment to ≥99% purity ensures that European laboratory professionals can rely on this material as a traceable, fit-for-purpose analytical standard supporting defensible scientific conclusions.

Principal Laboratory Applications and Research Methodologies

Bromonordiazepam 2.5mg Pellets serve multiple critical functions in contemporary analytical and pharmacological research, all conducted strictly within controlled laboratory environments by qualified personnel operating under appropriate institutional frameworks. The following applications represent the primary use cases for this compound as an analytical reference standard and research reagent:

Chemical Synthesis and Reference Standard Applications: Bromonordiazepam functions as a high-purity building block and reference standard in the synthesis and characterisation of novel 1,4-benzodiazepine analogues and structurally related designer benzodiazepines. Its well-defined molecular structure, incorporating the characteristic 7-bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one scaffold, makes it invaluable for reaction monitoring during the development of new GABA-A receptor ligands. In coordination chemistry research, Bromonordiazepam serves as a model ligand for studying benzodiazepine-site interactions on GABA-A receptors, enabling researchers to map structure-activity relationships within the classical benzodiazepine and N-desalkyl metabolite chemical space. The compound’s documented pharmacological profile as a positive allosteric modulator at the benzodiazepine binding site, with high affinity (IC₅₀ in the low nanomolar range), makes it particularly valuable for establishing detection limits and sensitivity thresholds in analytical method development.

Analytical Toxicology and Forensic Chemistry: As the major human metabolite of gidazepam and an emerging analyte in forensic casework, Bromonordiazepam has become a priority reference material in toxicology laboratories across Europe. This compound serves as a certified reference material for mass spectral library development in both LC-MS/MS and GC-MS platforms, enabling accurate identification in seized drug analysis, post-mortem toxicology casework, urine drug testing, and therapeutic drug monitoring applications. The material is essential for proficiency testing schemes organised by forensic science quality assurance programmes, where laboratories must demonstrate competence in detecting and quantifying classical benzodiazepines and their N-desalkyl metabolites. Method validation for toxicological screenings requires authenticated reference standards to establish calibration curves, determine limits of detection and quantification, and verify selectivity against structurally related compounds including gidazepam, nordazepam, desalkylflunitrazepam (fonazepam), oxazepam, norflurazepam, and other 1,4-benzodiazepine metabolites. The compound’s characteristic fragmentation ions and retention behaviour under standardised chromatographic conditions provide a reliable benchmark for method development and inter-laboratory comparison studies.

Pharmacological In Vitro Assays: In controlled pharmacological research, Bromonordiazepam is employed as a research tool for investigating GABA-A receptor positive allosteric modulation at the benzodiazepine binding site. The compound serves as a reference ligand in receptor-binding assays using recombinant GABA-A receptor subtypes expressed in cell lines, enabling investigation of subtype selectivity across α1-, α2-, α3-, and α5-containing receptors. Cellular uptake assays and metabolic stability profiling using human hepatocyte cultures utilise authenticated Bromonordiazepam reference material to characterise cytochrome P450-mediated biotransformation pathways, including monohydroxylation and nitro reduction pathways documented for structurally related N-desalkyl benzodiazepines. It is imperative to emphasise that all such applications are strictly limited to in vitro modelling systems and must never be extrapolated to suggest any form of human or animal administration.

Quality Control and Method Verification: Analytical laboratories utilising Bromonordiazepam as an internal standard or system suitability marker ensure consistent instrument performance across analytical runs. The compound’s characteristic retention time and mass spectral signature provide a reliable benchmark for verifying chromatographic separation efficiency and mass spectrometer calibration in multi-analyte methods targeting benzodiazepines and related psychoactive substances. In laboratories conducting broad-spectrum toxicology screening panels, Bromonordiazepam reference material supports ongoing verification of method performance, ensuring continued compliance with accreditation requirements under ISO/IEC 17025 and SWGDRUG guidelines for forensic drug analysis.

All applications described herein are exclusively for laboratory research purposes and must be conducted by qualified analytical chemists, biochemists, pharmacologists, or forensic toxicologists operating within appropriate institutional frameworks, including university research departments, contract research organisations (CROs), pharmaceutical R&D facilities, and government forensic laboratories.

Compound Stability, Optimal Storage, and Safe Handling Protocols

Bromonordiazepam exhibits moderate stability under appropriate storage conditions but requires careful handling to preserve analytical integrity and ensure laboratory safety. As a classical 1,4-benzodiazepine derivative with a 7-bromo substituent and a 2-fluorophenyl group at the 5-position, the compound demonstrates susceptibility to degradation when exposed to moisture, light, and elevated temperatures, necessitating strict adherence to recommended storage protocols.

Storage Requirements: The compressed pellet form should be stored desiccated at -20°C for long-term preservation, with protection from light achieved through amber-coloured storage vessels or opaque secondary containment. Desiccated conditions are mandatory to prevent hygroscopic degradation and potential hydrolysis of the lactam ring, which can compromise both chemical purity and physical integrity of the pellets. For short-term storage during active use periods (up to 4 weeks), the material may be maintained at +4°C in a dedicated laboratory refrigerator, provided that relative humidity remains below 40% and the container is returned to -20°C storage between uses. Repeated freeze-thaw cycles should be minimised to prevent physical stress on the pellet matrix and potential surface degradation.

Safe Handling Prerequisites: All handling of Bromonordiazepam reference material must occur within a certified chemical fume hood operating at appropriate face velocity (typically 0.4-0.6 m/s) to ensure adequate containment of any airborne particulates. Personnel must wear appropriate personal protective equipment, including nitrile gloves (changed frequently), safety goggles or a face shield, and a laboratory coat with long sleeves. Given the compound’s pharmacological activity as a GABA-A receptor positive allosteric modulator and its potential for central nervous system effects, particular care must be exercised to prevent accidental inhalation of dust or transfer to mucous membranes. Work surfaces should be covered with absorbent bench pads and decontaminated following each handling session using appropriate solvent wipes.

Solubility and Stock Solution Preparation: For in vitro analytical applications, Bromonordiazepam demonstrates good solubility in dimethyl sulfoxide (DMSO), methanol, and anhydrous ethanol, enabling preparation of stock solutions at concentrations up to 10-50 mM depending on the solvent system. DMSO is the preferred solvent for preparing concentrated stock solutions intended for serial dilution into aqueous assay buffers, as it provides excellent solubility and stability. Stock solutions in DMSO should be prepared fresh or stored in single-use aliquots at -20°C to avoid repeated freeze-thaw degradation. When preparing working solutions, the final DMSO concentration in assay systems should not exceed 1% (v/v) to prevent solvent-induced effects on biological targets. Methanol serves as an alternative solvent for applications where DMSO compatibility is a concern, particularly in LC-MS/MS workflows where methanol is commonly used as the mobile phase organic modifier.

Stability Considerations: Bromonordiazepam demonstrates reasonable stability in solid form when stored under recommended conditions, with minimal degradation observed over 12-month periods at -20°C in desiccated, light-protected containers. In solution, stability is more limited: DMSO stock solutions stored at -20°C remain stable for approximately 3 months, while working solutions in aqueous buffers should be prepared fresh and used within 24 hours. Light exposure accelerates degradation, particularly in solution, so all handling should occur under subdued lighting or using amber glassware where practical. The 7-bromo substituent and lactam functionality may undergo slow hydrolytic degradation upon prolonged exposure to moisture, particularly in alkaline solutions, so pH-neutral or slightly acidic buffer conditions are recommended for aqueous working solutions.

Technical Specifications and Molecular Attributes

Parameter Specification
IUPAC Name 7-Bromo-5-(2-fluorophenyl)-1,3-dihydro-1,4-benzodiazepin-2-one
CAS Registry Number 51518-16-0
Molecular Formula C₁₅H₁₀BrFN₂O
Exact Mass 332.9907 Da
Molecular Weight 333.16 g/mol
Physical State Compressed pellets (2.5 mg per pellet)
Colour Off-white to pale cream
Solubility Profile Soluble in DMSO (≥50 mM); soluble in methanol and anhydrous ethanol; sparingly soluble in aqueous buffers
Typical Purity (HPLC) ≥99%
Storage Conditions (Long-term) -20°C, desiccated, protected from light
Chemical Class 1,4-Benzodiazepine (N-desalkyl metabolite of gidazepam; designer benzodiazepine)
Analytical Applications LC-MS/MS reference standard, GC-MS library development, in vitro GABA-A receptor binding assays, forensic toxicology method validation, metabolic stability profiling, urine drug testing

Table 1: Technical specifications for Bromonordiazepam 2.5mg Pellets supplied by Pharma Research .eu. All values represent typical batch specifications; refer to batch-specific Certificate of Analysis for exact analytical data.

Pharma Research .eu: Your Premier EU Vendor for High-Purity Reagents

Pharma Research .eu transcends the conventional role of chemical supplier to serve as an indispensable partner in European scientific rigour and analytical excellence. Our commitment to quality extends beyond mere product provision: we operate under an ISO 9001-certified quality management system, ensuring that every batch of Bromonordiazepam and every reference material in our portfolio meets the exacting standards demanded by forensic laboratories, academic research institutions, and pharmaceutical R&D facilities across the European Union.

Our dedicated logistics infrastructure guarantees discreet, temperature-controlled shipping to all EU member states, preserving compound integrity from our warehouse to your laboratory bench. Understanding the critical nature of analytical reference standards in time-sensitive forensic casework and method validation projects, we maintain strategic inventory levels to ensure rapid dispatch—typically within 24 hours of order confirmation. All shipments comply with applicable EU regulations governing the distance sale of chemical substances, including comprehensive CLP (Classification, Labelling and Packaging) documentation and safety data sheets.

The Pharma Research .eu customer support team comprises individuals with genuine expertise in analytical chemistry and forensic toxicology, capable of engaging in meaningful technical discussions regarding specification requirements, certificate interpretation, and application-specific considerations. Whether you require clarification on CoA parameters, guidance on appropriate storage conditions for your laboratory environment, or assistance with procurement documentation for institutional purchasing systems, our specialists provide responsive, knowledgeable support.

We recognise that European laboratory professionals face increasing scrutiny regarding the provenance and quality of analytical reference materials used in forensic casework and regulated research. Pharma Research .eu addresses this imperative through comprehensive batch documentation, traceable analytical data, and unwavering commitment to supplying only materials that meet or exceed the specifications declared on our Certificates of Analysis. When your research demands certainty, when your analytical methods require authenticated standards, and when your professional reputation depends on defensible scientific conclusions—Pharma Research .eu stands ready as your trusted European partner in scientific advancement.


Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Buy Bromonordiazepam 2.5 MG Pellets”

Your email address will not be published. Required fields are marked *

Shipping & Delivery

MAECENAS IACULIS

Vestibulum curae torquent diam diam commodo parturient penatibus nunc dui adipiscing convallis bulum parturient suspendisse parturient a.Parturient in parturient scelerisque nibh lectus quam a natoque adipiscing a vestibulum hendrerit et pharetra fames nunc natoque dui.

ADIPISCING CONVALLIS BULUM

  • Vestibulum penatibus nunc dui adipiscing convallis bulum parturient suspendisse.
  • Abitur parturient praesent lectus quam a natoque adipiscing a vestibulum hendre.
  • Diam parturient dictumst parturient scelerisque nibh lectus.

Scelerisque adipiscing bibendum sem vestibulum et in a a a purus lectus faucibus lobortis tincidunt purus lectus nisl class eros.Condimentum a et ullamcorper dictumst mus et tristique elementum nam inceptos hac parturient scelerisque vestibulum amet elit ut volutpat.